Richard Wyse

Exenatide and the treatment of patients with Parkinson’s disease

Icíar Avilés-Olmos, John Dickson, Zinovia Kefalopoulou et al. · Journal of Clinical Investigation · 2013 · 494 citations

Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease

Icíar Avilés-Olmos, John Dickson, Zinovia Kefalopoulou et al. · Journal of Parkinson s Disease · 2014 · 291 citations · Full text

Outcome in neonates with Ebstein's anomaly

David S. Celermajer, Seamus Cullen, Ian D. Sullivan et al. · Journal of the American College of Cardiology · 1992 · 256 citations

Developmental Anomaly, Pediatrics, Maternal Health +5

Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome

Peter Scambler, Alisoun H. Carey, Richard Wyse et al. · Genomics · 1991 · 234 citations

Down Syndrome, Familial Digeorge Syndrome, Developmental Anomaly +9

The natural and “unnatural” history of congenitally corrected transposition

Ulla Lundström, Catherine Bull, Richard Wyse et al. · The American Journal of Cardiology · 1990 · 222 citations

Developmental Anomaly, Genetics, Congenital Disorders +3